Filtered By:
Nutrition: Fish Oil

This page shows you your search results in order of date.

Order by Relevance | Date

Total 40 results found since Jan 2013.

Use of Fish Oil and Mortality of Patients with Cardiometabolic Multimorbidity: A Prospective Study of UK Biobank
This study aimed to estimate the association between use of fish oil and mortality among patients with CMM. Methods and Results: In this prospective study based on UK Biobank, participants with ≥2 of cardiometabolic diseases (CMDs, including coronary heart disease [CHD], diabetes, hypertension, and stroke in this study) at recruitment were included.
Source: Nutrition, Metabolism, and Cardiovascular Diseases : NMCD - September 28, 2022 Category: Nutrition Authors: Tianqi Ma, Lingfang He, Yi Luo, Guogang Zhang, Xunjie Cheng, Yongping Bai Source Type: research

How to Lower Your Cholesterol Naturally
In the years following World War II, physicians in the U.S. and Europe noticed a surprising phenomenon: rates of heart attack and stroke fell dramatically in many places. Autopsies from this period also revealed reduced rates of atherosclerosis, which is a buildup of fatty arterial plaques that causes cardiovascular disease. At first, experts were perplexed. But as time passed, many concluded that wartime food deprivations and the forced shifts in people’s diets—namely, big reductions in the consumption of red meat and other animal products—contributed to the heart-health improvements. Later work, particu...
Source: TIME: Health - August 30, 2022 Category: Consumer Health News Authors: Markham Heid Tags: Uncategorized freelance healthscienceclimate heart health Source Type: news

Fatal adverse events of rivaroxaban combined with aspirin: an analysis using data from VigiBase
ConclusionsFatal AEs related to rivaroxaban combined with aspirin, including bleeding and ischemic events, have been reported mostly in the elderly, and sometimes involved medication errors. The fatal AEs mainly manifested as serious bleeding, and most of them occurred in patients with concurrent multiple risk factors. Monitoring coagulation during rivaroxaban treatment is recommended in very high-risk ASCVD populations, and attention should be paid to prevention of medication errors.
Source: European Journal of Clinical Pharmacology - July 1, 2022 Category: Drugs & Pharmacology Source Type: research

What the Science Says About the Health Benefits of Vitamins and Supplements
From multivitamins and melatonin to fiber and fish oil, Americans who are trying to boost their health and immunity have a plethora of supplements to choose from. An estimated 58% of U.S. adults ages 20 and over take dietary supplements, according to the U.S. Centers for Disease Control and Prevention, and the supplement industry is valued at more than $30 billion a year. Supplement use has been growing rapidly over the past few decades along with the wellness industry. “The popular belief is that a supplement is going to be helpful for promoting health,” says Fang Fang Zhang, a professor at Tufts University&rs...
Source: TIME: Health - April 28, 2022 Category: Consumer Health News Authors: Sandeep Ravindran Tags: Uncategorized Diet & Nutrition healthscienceclimate Source Type: news

Taking high doses of fish oil supplements may 'increase the risk of stroke'
MANY people may take fish supplements as they are lauded for their health benefits, Indeed, many researchers suggest that people eat oily fish or take supplements for arthritis. Nonetheless, the Mayo Clinic warns taking high doses of fish oil supplements might increase the risk of bleeding and possibly increase the risk of stroke.
Source: Daily Express - Health - March 22, 2022 Category: Consumer Health News Source Type: news

High-Dose Marine Omega-3s Raise Risk for Atrial Fibrillation High-Dose Marine Omega-3s Raise Risk for Atrial Fibrillation
Dr JoAnn Manson discusses the link between fish oil supplements, AF, and stroke.Medscape Ob/Gyn
Source: Medscape Today Headlines - November 17, 2021 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health Commentary Source Type: news

Fish, Cardiovascular Disease, and Mortality
Fish and shellfish (hereafter referred to as fish) are major sources of the dietary long-chain ω-3 fatty acids eicosapentaenoic acid (20:5n-3) and docosahexaenoic acid (22:6n-3) and also contain other nutrients, such as vitamin D, riboflavin, iodine, calcium, phosphorus, magnesium, potassium, zinc, and iron. The summed results of observational studies of fish intake, randomized clinical tria ls of fish oil supplements, and associated mechanistic and experimental studies suggest that regular fish consumption may decrease the incidence of myocardial infarction (MI) and coronary heart disease (CHD), with more uncertain effec...
Source: JAMA Internal Medicine - March 8, 2021 Category: Internal Medicine Source Type: research

Study: Fish Oil Doesn ’ t Seem To Prevent Heart Problems
This study is consistent with earlier trials. The US Food and Drug Administration approved the fish oil-based drug Vascepa for heart attack and stroke prevention in 2019. Nissen hopes the FDA will take a look at these studies and reconsider that decision. “But it’s hard to get something undone once the genie gets out of the bottle,” he said. An editorial in the journal that accompanies the study written by Dr. Gregory Curfman, assistant professor of medicine at Harvard Medical School, also suggested the FDA should require a postmarketing clinical trial of a high-dose of fish oil, such as Vascepa, vs. corn...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - November 16, 2020 Category: Consumer Health News Authors: CBS Boston Tags: Boston News Health Syndicated CBSN Boston CNN fish oil Source Type: news

The case for adding eicosapentaenoic acid (icosapent ethyl) to the ABCs of cardiovascular disease prevention.
Authors: Trivedi K, Le V, Nelson JR Abstract The high-purity eicosapentaenoic acid (EPA) prescription fish oil-derived omega-3 fatty acid (omega-3), icosapent ethyl (IPE), was recently approved by the United States Food and Drug Administration (FDA) for cardiovascular disease (CVD) prevention in high-risk patients. This approval is based on the 25% CVD event risk reduction observed with IPE in the pre-specified primary composite endpoint (cardiovascular [CV] death, nonfatal myocardial infarction, nonfatal stroke, coronary revascularization, or hospitalization for unstable angina) in the landmark Reduction of Cardio...
Source: Postgraduate Medicine - August 13, 2020 Category: Internal Medicine Tags: Postgrad Med Source Type: research

Benefits of Fish Oil Resurface, but Do They Hold Water? Benefits of Fish Oil Resurface, but Do They Hold Water?
Habitual fish oil consumption is linked to a lower risk for all-cause and CVD mortality, stroke, and MI, results of a large observational study suggest. One expert is ' skeptical that the results are real. 'Medscape Medical News
Source: Medscape Cardiology Headlines - March 12, 2020 Category: Cardiology Tags: Neurology & Neurosurgery News Source Type: news

Critical Differences Between Dietary Supplement and Prescription Omega-3 Fatty Acids: A Narrative Review
ConclusionConsumers and health care providers need to recognize critical differences between Rx and OM-3 dietary supplements to ensure appropriate use of each OM-3 product.
Source: Advances in Therapy - January 8, 2020 Category: Drugs & Pharmacology Source Type: research

AHA Names Top Heart Disease, Stroke Research Advances of 2019 AHA Names Top Heart Disease, Stroke Research Advances of 2019
A watch that detects atrial fibrillation, prescription fish oil for CV risk reduction, and the promise of dapagliflozin in HF are among the major advances for 2019, says the American Heart Association.Medscape Medical News
Source: Medscape Cardiology Headlines - January 2, 2020 Category: Cardiology Tags: Cardiology News Source Type: news

FDA Panel: Expand Use of Fish Oil Drug Vascepa
FRIDAY, Nov. 15, 2019 -- Approved use of the prescription-strength fish oil drug Vascepa should be widened to include more patients at risk for heart attack and stroke, a U.S. Food and Drug Administration advisory panel recommended Thursday. Vascepa...
Source: Drugs.com - Pharma News - November 15, 2019 Category: Pharmaceuticals Source Type: news

Rx Fish Oil Cuts Heart Dangers in Statin Takers
The study suggests that the prescription fish oil pill, not to be confused with over-the-counter supplements, reduces the lifetime risk of dying from heart disease; having a non-fatal heart attack or stroke; or needing heart surgery or hospitalization for a heart complication.
Source: WebMD Health - March 18, 2019 Category: Consumer Health News Source Type: news